RxDoctor Payments Data

Erika Crowell, NP

Family · Lawrenceburg, TNNPI 1417324211

Payments from drug & device makers

$17,593in general payments, 2019–2025

Across 893 payments — averaging $19.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$2K
  • AbbVie$1K
  • Novartis$1K
  • AstraZeneca$1K
  • ANI Pharmaceuticals, Inc.$1K
  • Biogen$972
  • plus $11K from 54 others

What the payments were for

  • Food & beverage$17,25498%
  • Education$3402%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.53$1,617
AbbVie80$1,278
Novartis53$1,081
AstraZeneca(2 entities)45$1,061
ANI Pharmaceuticals, Inc.49$1,052
Biogen47$972
Neurocrine Biosciences, Inc.28$705
EMD Serono, Inc.41$688
Lilly USA, LLC41$646
Pfizer47$606
Teva Pharmaceuticals USA, Inc.25$567
SK Life Science, Inc.32$530
Harmony Biosciences LLC22$528
Jazz Pharmaceuticals Inc.20$496
Eisai Inc.36$451
TG Therapeutics, Inc.15$345
Neurelis, Inc.20$340
Axsome Therapeutics, Inc.18$319
Acadia Pharmaceuticals Inc15$282
Lundbeck LLC14$242
Banner Life Sciences, LLC12$235
Catalyst Pharmaceuticals, Inc.11$232
Argenx US, Inc.10$209
Bristol Myers Squibb13$207
Grifols USA, LLC10$189
Kyowa Kirin, Inc.8$180
Johnson & Johnson13$171
Biohaven Pharmaceutical Holding Company Ltd.9$164
CSL Behring6$161
Inspire Medical Systems, Inc.5$147
Otsuka America Pharmaceutical, Inc.7$129
Octapharma USA, Inc.5$126
Avadel CNS Pharmaceuticals, LLC4$117
Sumitomo Pharma America, Inc.6$112
Alnylam Pharmaceuticals Inc.6$111
Avion Pharmaceuticals6$110
Mallinckrodt Hospital Products Inc.4$102
Upsher-smith Laboratories LLC6$97
Impel Pharmaceuticals Inc.5$94
Impel Pharmaceuticals LLC4$86
Tanabe Pharma America, Inc.4$68
Merz Pharmaceuticals, LLC3$67
Genentech USA, Inc.2$60
Vanda Pharmaceuticals Inc.2$54
Azurity Pharmaceuticals, Inc.3$51
Sanofi2$50
Amgen3$49
Amneal Pharmaceuticals LLC3$48
Takeda Pharmaceuticals U.S.A., Inc.2$47
Aucta Pharmaceuticals, Inc.2$45
Scilex Pharmaceuticals Inc.2$36
MDD US Operations, LLC2$36
Boston Scientific2$34
Ipsen Biopharmaceuticals, Inc2$34
Avanir Pharmaceuticals, Inc.1$31
Revance Therapeutics, Inc.1$27
Novo Nordisk2$26
Sunovion Pharmaceuticals Inc.2$20
Cycle Pharmaceuticals Inc1$16
Alfasigma USA, Inc.1$12

How this compares

$17,593 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$91,481
Medicare patients
438
Services billed
1,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuplazidPimavanserin Tartrate35$183,176
GammakedImmune Globul G/Gly/Iga Avg 4622$173,919
IngrezzaValbenazine Tosylate18$149,278
AustedoDeutetrabenazine12$144,293
BriviactBrivaracetam65$103,976
Aimovig AutoinjectorErenumab-Aooe44$45,852
QuliptaAtogepant38$44,225
XcopriCenobamate37$44,141
UbrelvyUbrogepant37$40,996
Nurtec OdtRimegepant Sulfate37$40,842
NourianzIstradefylline14$38,676
Emgality PenGalcanezumab-Gnlm36$25,125
BotoxOnabotulinumtoxina19$25,087
FycompaPerampanel16$22,251
TopamaxTopiramate19$18,807

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$282$183,17635 claims
Neurocrine Biosciences, Inc.Ingrezza$705$149,27818 claims
Teva Pharmaceuticals USA, Inc.Austedo$567$144,29312 claims
UCB, Inc.Briviact, Neupro, Vimpat$1,617$129,72993 claims
AbbVieQulipta, Ubrelvy, Botox$1,278$110,30894 claims
PfizerNurtec Odt, Zavzpret$606$58,51253 claims
SK Life Science, Inc.Xcopri$530$44,14137 claims
Kyowa Kirin, Inc.Nourianz$180$38,67614 claims
Eisai Inc.Fycompa$451$22,25116 claims
Upsher-smith Laboratories LLCTopiramate$97$2,025210 claims
Amneal Pharmaceuticals LLCPyridostigmine Bromide$48$1,93516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.

Other family in Lawrenceburg

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →